| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-05-2922 |
| P698 | PubMed publication ID | 16452229 |
| P2093 | author name string | Seetharaman Balasenthil | |
| Rakesh Kumar | |||
| C Marcelo Aldaz | |||
| Suresh K Rayala | |||
| Rui-An Wang | |||
| Amjad H Talukder | |||
| Christopher J Barnes | |||
| Sohaib Khan | |||
| Robbin Tharakan | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 1694-1701 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation | |
| P478 | volume | 66 |
| Q34119065 | A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions |
| Q64929145 | A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells. |
| Q35684445 | A role for estrogen receptor phosphorylation in the resistance to tamoxifen |
| Q37058519 | A tale of two Paks |
| Q36994934 | AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. |
| Q80282002 | Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer |
| Q36568006 | Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer |
| Q93118509 | Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer |
| Q26996464 | Cooperating transcription factors mediate the function of estrogen receptor |
| Q42366599 | Cross-talk between p21-activated kinase 4 and ERα signaling triggers endometrial cancer cell proliferation |
| Q36860992 | Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance |
| Q36199639 | Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis |
| Q36589361 | Derailed estrogen signaling and breast cancer: an authentic couple. |
| Q37715015 | Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer |
| Q38505488 | ER regulates an evolutionarily conserved apoptosis pathway |
| Q36210983 | ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression. |
| Q90087899 | Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion |
| Q24336790 | Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian cells |
| Q34112728 | Estrogen receptor mutations and changes in downstream gene expression and signaling |
| Q37725983 | Evolving pathway-driven biomarkers in breast cancer |
| Q35786706 | Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305. |
| Q30370259 | Identification of phosphorylation sites in betaPIX and PAK1 |
| Q30419413 | Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer |
| Q34768156 | Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing |
| Q38186042 | Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. |
| Q28308069 | Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α |
| Q34417159 | Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies? |
| Q28266864 | Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations |
| Q38060732 | PAK signaling in cancer |
| Q37494233 | PAK signaling in oncogenesis. |
| Q36813554 | PAK1 translocates into nucleus in response to prolactin but not to estrogen |
| Q30425265 | PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin |
| Q84830597 | PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance |
| Q37376062 | Pak protein kinases and their role in cancer |
| Q37091709 | Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study |
| Q30441001 | Pathways to tamoxifen resistance |
| Q35001373 | Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription |
| Q24301847 | Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines |
| Q28269146 | Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells |
| Q34070890 | Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity |
| Q27319440 | Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover |
| Q37198642 | Phosphorylation: a fundamental regulator of steroid receptor action |
| Q36031247 | Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells |
| Q24336162 | RAC3 is a pro-migratory co-activator of ERα |
| Q35854151 | Rac signaling in breast cancer: a tale of GEFs and GAPs. |
| Q27650581 | Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase |
| Q36671906 | Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer |
| Q33700933 | Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatment |
| Q36909572 | Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. |
| Q37459177 | Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation |
| Q38432603 | Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells. |
| Q38779105 | Structure, biochemistry, and biology of PAK kinases |
| Q36918232 | Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1. |
| Q33382611 | Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites |
| Q92126767 | The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer |
| Q36881741 | The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis |
| Q37006174 | The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies |
| Q27016620 | The role of p21-activated kinases in hepatocellular carcinoma metastasis |
| Q41894651 | Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration |
| Q36078608 | Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion |
| Q86422822 | WITHDRAWN: Sliding p21-Activated Kinase 1 to Nucleus Impacts Tamoxifen Sensitivity |
| Q30156984 | c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation |
| Q35720268 | p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation. |
| Q36528197 | p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer |
| Q37886485 | p21-activated kinase 1: PAK'ed with potential |
| Q28269662 | p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells |
| Q28242189 | p21-activated kinases in cancer |
Search more.